Yakult, 4SC in cancer deal

4SC AG (Xetra:VSC) granted Yakult Honsha Co. Ltd. (Tokyo:2267) exclusive rights in Japan to develop and commercialize cancer candidate resminostat. The pan- histone deacetylase (HDAC) inhibitor is in ...